Potential side effect of high-dose corticosteroid relapse treatment: acute generalized exanthematous pustulosis (AGEP).

Abstract

INTRODUCTION:

High-dose glucocorticosteroids (GC) are the treatment of choice for acute relapses in patients with multiple sclerosis as proven by several controlled clinical trials. The common adverse effects of GC are well known.

CASE PRESENTATION:

In this study, we report on the exceptional case of a young female treated with intravenous high-dose prednisolone for optic neuritis who developed acute generalized exanthematous pustulosis (AGEP). AGEP is a rare cutaneous adverse reaction induced most frequently by antimicrobial or antihypertensive drugs and viral infections. It is characterized by a febrile erythematous and pustular rash and blood granulocytosis.

CONCLUSION:

In our patient, switching to dexamethasone for the next relapse was tolerated well and is an option for treatment. AGEP is a rare adverse effect of corticosteroid treatment.

• Authors: T Ziemssen, A Bauer, M Bär
• Journal: Multiple sclerosis (Houndmills, Basingstoke, England) (Mult Scler) Vol. 15 Issue 2 Pg. 275-7 (Feb 2009) ISSN: 1352-4585 [Print] England
• PMID: 18805845 (Publication Type: Case Reports, Journal Article)

Chemical References

• Adrenal Cortex Hormones

Topics

• Acute Disease
• Adrenal Cortex Hormones (administration & dosage, adverse effects)
• Dose-Response Relationship, Drug
• Drug Eruptions (pathology)
• Exanthema (chemically induced, pathology)
• Female
• Humans
• Optic Neuritis (drug therapy)
• Skin Diseases, Vesiculobullous (chemically induced, pathology)
• Young Adult